Sanofi: Dupixent Approved in China as the First-Ever Biologic Medicine for Patients With COPD
September 28, 2024
September 28, 2024
PARIS, France, Sept. 28 (TNSres) -- Sanofi, a life sciences company, issued the following news release:
* * *
Dupixent approved in China as the first-ever biologic medicine for patients with COPD
* Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function, and also improved health-related quality of lif . . .
* * *
Dupixent approved in China as the first-ever biologic medicine for patients with COPD
* Approval follows EU approval of Dupixent for adults with COPD with raised blood eosinophils, and is based on two landmark phase 3 studies showing Dupixent significantly reduced exacerbations, improved lung function, and also improved health-related quality of lif . . .